Olink

Olink®
Part of Thermo Fisher Scientific

Connecting Genomics and Proteomics to Identify Protein Biomarkers for Adult and Youth-Onset Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Diabetes, 2022

Ghanbari F., Yazdanpanah N., Yazdanpanah M., Richards J., Manousaki D.

Disease areaApplication areaSample typeProducts
Metabolic Diseases
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Type 2 diabetes shows an increasing prevalence in both adults and children. Identification of biomarkers for both youth and adult-onset type 2 diabetes is crucial for development of screening tools or drug targets. In this study, using two-sample Mendelian randomization (MR), we identified 22 circulating proteins causally linked to adult type 2 diabetes and 11 proteins with suggestive evidence for association with youth-onset type 2 diabetes. Among these, colocalization analysis further supported a role in type 2 diabetes for C-type mannose receptor 2 (MR odds ratio [OR] 0.85 [95% CI 0.79–0.92] per genetically predicted SD increase in protein level), MANS domain containing 4 (MR OR 0.90 [95% CI 0.88–0.92]), sodium/potassium-transporting ATPase subunit β2 (MR OR 1.10 [95% CI 1.06–1.15]), endoplasmic reticulum oxidoreductase 1β (MR OR 1.09 [95% CI 1.05–1.14]), spermatogenesis-associated protein 20 (MR OR 1.12 [95% CI 1.06–1.18]), haptoglobin (MR OR 0.96 [95% CI 0.94–0.98]), and α1–3-N-acetylgalactosaminyltransferase and α1–3-galactosyltransferase (MR OR 1.04 [95% CI 1.03–1.05]). Our findings support a causal role in type 2 diabetes for a set of circulating proteins, which represent promising type 2 diabetes drug targets.

Read publication ↗